GLP-1 receptor agonists work by mimicking a naturally occurring hormone produced in the intestines after eating
(b) Single small case series in knee pain A peer-reviewed article (Lee et al., Alternative Therapies in Health & Medicine , ~2021) describes: 12 patients with chronic knee pain Treated with intra-articular BPC-157, often combined with TB-500 7 of 12 reported symptom improvement lasting several months This study has major limitations: No control group No blinding No standardized outcomes (no KOOS, WOMAC, or imaging) Very small sample size Mixed interventions Conclusion: This study cannot demonstrate true benefit
When you take a GLP-1 medication like semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda), it: Slows down how quickly food leaves your stomach, which keeps you feeling full for longer Signals to your brain that youre satisfied, reducing those constant thoughts about food and snacking Helps your pancreas release the right amount of insulin when your blood sugar rises These medications were initially developed for type 2 diabetes, which is why you might have heard of Ozempic being used off-label for weight loss
Root cause analysis
5-Amino-1MQ inhibits NNMT, preventing fat cells from resisting metabolic activation
De Luca P, Cassandro C, Ralli M, et al
